Sort
51,570 grants matching “autoimmune disease”
Role of a novel risk loci HAVCR2 of late-onset Alzheimer's disease in the regulation of microglial response in neurodegeneration
$831,274Vijay K Kuchroo · Brigham And Women'S Hospital · R01 · FY2023 · AG
The Integrated Stress Response in Human Islets During Early T1D
$831,197Raghavendra G Mirmira · University Of Chicago · U01 · FY2020 · DK
Precision Phenomics to Personalize Drug Therapy (P3DT)
$831,119Joshua C. Denny · Vanderbilt University Medical Center · P50 · FY2019 · GM
Engineering 2nd generation 5MCARs to monitor and treat Type-I Diabetes
$831,071Michael S Kuhns · University Of Arizona · R01 · FY2023 · DK
Engineering synthetic immune cells with modular sentinel and therapeutic functions for T1D
$830,753Wendell A Lim · University Of California, San Francisco · R01 · FY2022 · DK
Medication Adherence in Children Who Had a Liver Transplant (MALT)
$830,524Eyal Shemesh · Icahn School Of Medicine At Mount Sinai · R01 · FY2009 · DK
Identification and biological effects of microbiome-derived sulfated metabolites
$830,414Abigail Sloan Devlin · Harvard Medical School · R01 · FY2025 · DK
Genetic and Immuno-inflammatory Drivers of Post-acute Pulmonary Sequelae of SARS-CoV-2
$830,331Steven B Abramson · New York University School Of Medicine · R01 · FY2024 · HL
STUDIES TO EVALUATE THE POTENTIAL FOR ENVIRONMENTAL&THERAPEUTIC AGENTS TO INDUCE IMMUNOTOXICITY - In vivo
$830,232Florence Burleson · · N01 · FY2024 · ES
UAB Multidisciplinary Clinical Research Center
$829,938S Louis Bridges · University Of Alabama At Birmingham · P60 · FY2014 · AR
Role of a novel risk loci HAVCR2 of late-onset Alzheimer's disease in the regulation of microglial response in neurodegeneration
$829,912Vijay K Kuchroo · Brigham And Women'S Hospital · R01 · FY2024 · AG
Early life regulation of microbiota specific thymic T cell development
$829,651Matthew Bettini · University Of Utah · R01 · FY2023 · AI
Aberrant DNA Repair and Lupus
$829,417Joann B Sweasy · University Of Nebraska Medical Center · R35 · FY2024 · ES
Isochoric Pressure Based Preservation of Ovarian Tissue
$829,142Bradley P Weegman · Sylvatica Biotech, Inc. · R44 · FY2022 · HD
Development of an engineered CCL20 protein as a lead therapeutic molecule for psoriasis
$829,097Brian F Volkman · Xlock Biosciences, Llc · R44 · FY2021 · AR
Quantifying proteins in plasma do democratize personalized medicine for patients with type 1 diabetes
$828,866Andrew N Hoofnagle · University Of Washington · U01 · FY2025 · DK
The biophysics of skin-neuron sensory tactile organs and their sensitivity to mechanical and chemical stress
$828,786Miriam B Goodman · Stanford University · R35 · FY2025 · NS
Engineering 2nd generation 5MCARs to monitor and treat Type-I Diabetes
$828,648Michael S Kuhns · University Of Arizona · R01 · FY2024 · DK
Project 2
$828,618Jeroen Roose · University Of California, San Francisco · P01 · FY2017 · AI
Suppression and Exacerbation of B and T cell Responses *
$828,438Ignacio E. Sanz · University Of Rochester · U19 · FY2006 · AI
Chronic Graft Destruction: Interplay of Allo- and Autoantibodies and Nonadherence
$828,397Steven A Webber · Vanderbilt University · U01 · FY2015 · AI
An Integrative Multi-Omics Approach to Elucidate Sex-Specific Differences in Alzheimers Disease
$828,195Marina Sirota · University Of California, San Francisco · R01 · FY2019 · AG
The Risk of Myocardial Infarction in Patients with Psoriasis
$828,093Joel M Gelfand · University Of Pennsylvania · R01 · FY2010 · HL
TL1A and its receptor DR3 in normal and autoimmune T cell responses
$827,944Richard M Siegel · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2017 · AR
A Novel Immunological-Directed Synthetic Biology-Based Drug for the Treatment of Multiple Sclerosis
$827,713Christian Furlan Freguia · Rise Therapeutics, Llc · R44 · FY2025 · AI